SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Cancer

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (16)4/19/2001 9:27:39 PM
From: scaram(o)uche  Read Replies (1) of 1840
 
You enjoyed the last one, and there's the Seattle touch. It's fun sharing my background. Some will be turned off........

Approaching Biology From a Different Angle

SCIENTIST AT WORK / Leroy Hood
By ANDREW POLLACK


Message 15677887

Proc Natl Acad Sci U S A 1982 Jun;79(11):3613-7

Specific recognition of the product of a transferred major
histocompatibility complex gene by cytotoxic T lymphocytes.

Woodward JG, Orn A, Harmon RC, Goodenow RS, Hood L, Frelinger JA.

Nature 1982 Jun 3;297(5865):415-7

Product of a transferred H-2Ld gene acts as restriction element for
LCMV-specific killer T cells.

Orn A, Goodenow RS, Hood L, Brayton PR, Woodward JG, Harmon RC, Frelinger JA.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext